Strategies of drug companies to optimize the sales of their psychiatric drugs
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-12-01
|
Series: | BMC Psychiatry |
id |
doaj-55eb7e8d27d5437ab7cb9ec6b4e3c116 |
---|---|
record_format |
Article |
spelling |
doaj-55eb7e8d27d5437ab7cb9ec6b4e3c1162020-11-25T02:34:00ZengBMCBMC Psychiatry1471-244X2007-12-017Suppl 1S9010.1186/1471-244X-7-S1-S90Strategies of drug companies to optimize the sales of their psychiatric drugsWhitaker Robert |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Whitaker Robert |
spellingShingle |
Whitaker Robert Strategies of drug companies to optimize the sales of their psychiatric drugs BMC Psychiatry |
author_facet |
Whitaker Robert |
author_sort |
Whitaker Robert |
title |
Strategies of drug companies to optimize the sales of their psychiatric drugs |
title_short |
Strategies of drug companies to optimize the sales of their psychiatric drugs |
title_full |
Strategies of drug companies to optimize the sales of their psychiatric drugs |
title_fullStr |
Strategies of drug companies to optimize the sales of their psychiatric drugs |
title_full_unstemmed |
Strategies of drug companies to optimize the sales of their psychiatric drugs |
title_sort |
strategies of drug companies to optimize the sales of their psychiatric drugs |
publisher |
BMC |
series |
BMC Psychiatry |
issn |
1471-244X |
publishDate |
2007-12-01 |
work_keys_str_mv |
AT whitakerrobert strategiesofdrugcompaniestooptimizethesalesoftheirpsychiatricdrugs |
_version_ |
1724810879423217664 |